Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 life science REIT, closed at $42.65 on October 20, 2026, about 6.7 times the midpoint of its 2026 FFO guidance. REIT investor Mr Neutral Man named Alexandria among his favorite tax-loss-selling candidates for a 2027 recovery, a contrarian bet after a 45% dividend cut and falling occupancy. Third-quarter results come after the close on October 26, 2026, and 2027 guidance is due at the December 2, 2026 Investor Day.
This is journalism and commentary, not investment advice. We hold no position unless stated.
Key facts
- Ticker and exchange: Alexandria Real Estate Equities, Inc., ARE, New York Stock Exchange.
- Situation type: contrarian long on a beaten-down office and lab REIT, framed as a tax-loss-selling rebound.
- The call: Mr Neutral Man (@Mr_Neutral_Man) listed ARE among his favorite 2026 tax-loss candidates on October 19, 2026, at a $41.62 prior close.
- Valuation: $42.65 at the October 20, 2026 close, about 6.7x the $6.40 midpoint of 2026 FFO per share, as adjusted, by our math.
- Dividend: $0.72 a quarter, cut 45% from $1.32 in December 2025; about a 6.8% yield at $42.65.
- Catalysts: third-quarter results on October 26, 2026 and 2027 guidance on December 2, 2026.
- Main risk: occupancy of 86.9% and leverage of 7.0x net debt to Adjusted EBITDA as of June 30, 2026.
Is Alexandria Real Estate a good bet right now?
The bull case is price. At $42.65, Alexandria trades at about 6.7 times 2026 FFO guidance of $6.35 to $6.45 a share, per the Q2 2026 release. The stock is down about 12.9% from $48.94 at the end of 2025.
The bear case is that FFO is still shrinking. Second-quarter FFO per share, as adjusted, was $1.73, down from $2.33 a year earlier. Management expects fourth-quarter FFO at the lower end of $1.40 to $1.50.
Why are investors bullish on Alexandria Real Estate?
- A low multiple on a smaller dividend. The 2Q26 payout ratio was 42% of FFO, leaving cash for construction and debt reduction.
- Asset sales underway. Alexandria targets $2.9 billion of dispositions and partial-interest sales in 2026; $1.33 billion was completed or pending as of August 3, 2026.
- No new stock. The company said it does not expect to issue common equity in 2026, and its $500 million buyback was unused as of June 30.
- Signed leases waiting. Occupancy rises to 90.9% including signed leases not yet occupied.
- Year-end selling. Mr Neutral Man's thesis is that tax-loss selling into December can leave the stock cheap for a 2027 rebound.
Who's making this call and why?
Mr Neutral Man is a REIT investor with about 13,000 followers who describes his approach as buying real estate in the public markets at discounts to private market values. On October 19, 2026 he asked for favorite tax-loss candidates and answered with ARE, LINE and NXRT: "Basically my entire REIT book probably all have the best torque."
Asked whether he likes ARE, he replied: "In small size." On October 21 he argued that patient capital can "buy really cheap companies that won't work in 12 months but will in 3 yrs."
Track record. Mr Neutral Man is not yet scored on our scoreboard.
Another supporter, with caveats. Jussi Askola, CFA, CEO of Leonberg Capital and author of "The REIT Advantage," called Alexandria his worst investment of 2025 on February 12, 2026, then added: "Even then, I remain bullish." In September he wrote that life science REITs are among the biggest discounts in the sector. In our backtest of 22 of his REIT calls from February to April 2026, he went 3-19 against the S&P 500 at 180 days, and his February ARE call trailed by 21.8 points.
Who disagrees?
- BMO Capital. BMO cut Alexandria to Underperform on October 12, 2026, lowering its target to $41 from $48 and projecting 2027 core FFO of $4.74 a share, down 26.3%, per Investing.com. On that estimate, $42.65 is about 9.0x, by our math.
- Same-property decline. Same-property net operating income fell 10.6% in the second quarter of 2026.
- Leverage. Net debt and preferred stock were 7.0x annualized Adjusted EBITDA, against a fourth-quarter 2026 target of 5.6x to 6.2x that depends on asset sales.
- 2027 Move-outs. Alexandria expects about $100.5 million of annual rent from 2027 lease expirations to sit empty for 12 to 24 months.
- Rent resets. Renewal rents fell 15.0% in the first quarter of 2026 and 0.7% in the second.
What are the key facts to verify?
- The Q2 2026 release for FFO, occupancy, leverage and the asset-sale plan.
- The Q3 call notice for the October 26 release and October 27 call.
- The 3Q26 dividend declaration of $0.72 a share.
- Whether the $1.16 billion of pending sales closed in the third quarter.
What would prove it right or wrong?
Right: the third quarter shows the asset sales closing, leverage heading toward 6.2x, occupancy holding near 86% to 88%, and 2027 guidance on December 2 coming in above BMO's $4.74.
Wrong: sales slip, occupancy falls further as 2027 leases expire, 2027 FFO guidance confirms a drop of 25% or more, or the board cuts the $0.72 dividend again.
This is journalism and commentary, not investment advice. We hold no position unless stated.